Raymond James & Associates Acrivon Therapeutics, Inc. Transaction History
Raymond James & Associates
- $146 Billion
- Q1 2024
A detailed history of Raymond James & Associates transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 10,200 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,200Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACRV
# of Institutions
47Shares Held
10.7MCall Options Held
0Put Options Held
0-
Perceptive Advisors LLC New York, NY3.01MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.68MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA1.65MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio
-
Black Rock Inc. New York, NY744KShares$00.0% of portfolio